Board summary
Key figures
30,087
Registered population
60.8% aged 18–64
17.2%
Aged 65+
ICB 19.9% · England 17.9%
14.7%
Ethnic minority (non-White)
6.0% Asian · England 9.6%
26.6%
In IMD quintile 1
ICB 17.1% · England 21.0%
~7,586
Core20 residents (est.)
Resident basis; registered basis ~7,949 · see page 3
4,571
Hypertension register
+3.22% in 3 yrs · England +5.60%
243
SMI register
8.6% of Medway (LAD)'s
514
COPD register
Reviews +13.48% in 3 yrs
Forecast to 2030
5,037
Hypertension patients, 2030
+466 on today
71.0%
QRISK ≥20% on statins, 2030
+6.06pp over 3 yrs
4.7%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Under-eighty blood pressure control fell over three years.
Under-80 BP control is 60.1% (England 67.8%) after falling 9.4% (-6.3 pp; England +3.2%, +2.1 pp), which may reflect recall gaps.
Primary-prevention lipid therapy trails England and Medway.
QRISK ≥ 20% lipid therapy is 56.6% (Medway 64.0%, England 63.6%) and non-CVD diabetes statin prescribing is 64.8% (England 73.2%).
Asthma review coverage rose above comparator benchmarks.
Annual asthma review coverage rose 22.3% (+12.4 pp) over three years to 67.8%, ahead of Medway (62.6%) and England (65.7%).
Population, age and ethnicity
A younger list with 22.1% aged 0-17 sits alongside 14.7% ethnic minority resident share
Gillingham South PCN serves 30,087 registered patients across four practices. Children aged 0-17 comprise 22.1% (6,636 patients), above Medway (21.6%), NHS Kent and Medway ICB (20.7%) and England (19.6%). Conversely, 17.2% are aged 65+ (5,162 patients), below Medway (17.9%), the ICB (19.9%) and England (17.9%). Census residents in associated areas are 85.3% White and 14.7% ethnic minority, against 84.3% in Medway, 88.6% in the ICB and 81.1% in England. Projected list growth to 2030 is 1.9% (Medway 7.0%, ICB 6.0%, England 2.3%; unverified projection methodology).
Age profile
65+: ICB 19.9%, England 17.9%
Ethnicity
Older people · falls rows are Medway (LAD) local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Medway LA) | 1,507 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 76.7% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 54.8% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Medway LA) | 740 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Medway LA) | 19.5 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Deprivation reaches 26.6% across the PCN and spans 44.0 pp between practices
Core20 share is 26.6% across the PCN, above Medway (23.1%), NHS Kent and Medway ICB (17.1%) and England (21.0%). Practice shares span a range of 44.0 pp. Napier Road Surgery records the highest concentration at 44.0% (1,354 estimated patients), while Pump Lane Surgery records 0.0%. Woodlands Family Practice holds the largest volume with 5,465 estimated patients (27.1%). Modelled weighted practice share is 26.4%, differing slightly from the PCN rate. Outreach requires balancing concentrated deprivation against large practice volume.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
243
SMI register
0.80% recorded prevalence
194
Learning disability register
0.64% recorded prevalence
24
Care homes, 724 beds
In the PCN catchment
8.9%
Provide unpaid care
Medway (LAD), Census 2021
The PCN records 243 patients on the severe mental illness register (0.8% prevalence, below Medway 0.9%, ICB 0.9% and England 1.0%) and 194 on the learning disability register (0.6% vs Medway 0.7%, ICB 0.6% and England 0.6%). The catchment includes 24 care homes with 724 beds, though resident occupancy is unconfirmed.
Severe mental illness: physical health checks
Severe mental illness recorded BMI checks fell 4.4 pp over three years to 78.0% (England +5.1 pp to 82.1%), while blood pressure checks reached 78.5% (England 83.4%) across 243 registered patients.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
4,571
Hypertension register
+3.22%
Register growth, 3 yrs
Medway (LAD) +3.74% · England +5.60%
−6.26pp
BP control, under 80
≤140/90 · +3.24pp aged 80+
+466
More patients by 2030
Forecast 5,037 (15.94%)
Hypertension case-finding and control
Hypertension QOF recorded prevalence is 15.0% (4,571 patients), compared with 15.4% in Medway (LAD), 16.2% in NHS Kent and Medway ICB, and 15.2% in England. Recent blood pressure monitoring is 85.0% (England 90.0%), and overall treatment to target is 64.7% (England 70.3%). For patients aged under 80, blood pressure control to <= 140/90 mmHg is 60.1% (England 67.8%) after falling 6.3 pp or 9.4% (England +2.1 pp, +3.2%); at Woodlands Family Practice it is 54.4%. Crude prevalence differences do not establish undiagnosed disease.
Lipids and statins
Statin treatment for QRISK ≥ 20% is 56.6% (England 63.6%, Medway (LAD) 64.0%), and diabetes without cardiovascular disease is 64.8% (England 73.2%). Secondary prevention in diabetes reaches 83.9% (England 84.4%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 45,947 | £1.60 | £1.90 | £1.86 | £73,515 |
| Cardiovascular (all), 2025 | 62,009 | £2.61 | £3.57 | £3.33 | £161,843 |
In 2026, the PCN prescribed 45,947 items of lipid-regulating drugs at £1.60 per item, compared with £1.87 in Medway (LAD), £1.90 in NHS Kent and Medway ICB, and £1.86 in England (£11,946 less than at England's unit cost, across 45,947 items).
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+22.30%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+4.73%
Asthma prevalence, PCN 3-yr % change
Asthma annual review coverage reached 67.8% (England 65.7%, Medway (LAD) 62.6%) after rising 22.3% over three years (England +4.4%), though about 560 of 1,752 asthma patients lack a recorded review. COPD reviews reached 74.7% (England 76.4%) after rising 13.5% (England +2.8%). Conversely, COPD recorded prevalence fell 3.7% over three years to 1.7% across 514 patients (England +2.6% to 1.9%). Crude prevalence differences do not establish undiagnosed disease.
Cancer register and children's immunisation
The cancer register grew +11.3% over three years to 3.8% across 1,151 patients (England +9.0% to 3.8%). Age-5 pre-school boosters trail the 95.0% target: MMR dose 2 is 87.5% and 4-in-1 is 86.5%. Across the PCN, MMR coverage drops 4.8 pp between dose 1 and dose 2.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Kent and Medway ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,630
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Kent and Medway ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 82.1% | 85.4% | 23% | 1,509 |
| Prostate | 54.4% | 53.2% | 37% | 1,435 |
| Lung | 29.4% | 33.8% | 21% | 1,109 |
| Bowel | 48.2% | 47.0% | 29% | 1,013 |
| Skin cancer | 87.5% | 87.8% | 23% | 562 |
In 2022, 55.6% of cancers with a known stage across NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384), in line with England (55.3%) but 19.4 pp below the 75.0% national ambition by 2028. Staging completeness was 63.6% (8,384 of 13,189 cancers; England 67.0%), representing an ICB gap of about 1,630 early-stage cases. These figures describe the wider system, not PCN performance. Locally, PCN breast screening coverage is 67.0% (England 69.9%), varying from 62.0% at Napier Road Surgery and 65.1% at Woodlands Family Practice to 77.5% at Pump Lane Surgery.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), Medway NHS Foundation Trust achieved 81.6% on the 62-day cancer treatment standard, 3.4 pp below the 85.0% standard, exceeding NHS Kent and Medway Integrated Care Board (75.9%) and England (71.2%); Maidstone and Tunbridge Wells NHS Trust reached 87.4% and Mid and South Essex NHS Foundation Trust 50.2%. On the 28-day faster diagnosis standard, Medway NHS Foundation Trust achieved 77.8% (ICB 76.8%, England 79.3%). For 6-week diagnostic waits, Medway NHS Foundation Trust recorded 0.7% for MRI and 1.9% for colonoscopy (England 21.4% and 30.8%), while echocardiography was 36.6% (England 28.5%).
| Pathways within standard (%) | Medway | Maidstone and Tunbridge Wells | Mid and South Essex | Kent and Medway ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 77.77 | 81.78 | 67.45 | 76.78 | 79.32 |
| 31-day treatment (96%) | 99.62 | 98.35 | 81.88 | 95.84 | 92.50 |
| 62-day referral to treatment (85%) | 81.64 | 87.43 | 50.25 | 75.93 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Medway | Maidstone and Tunbridge Wells | Mid and South Essex | England |
|---|---|---|---|---|
| MRI | 0.68 | 0.92 | 23.35 | 21.40 |
| CT | 0.00 | 0.51 | 6.07 | 9.92 |
| Echocardiography | 36.62 | 2.57 | 65.05 | 28.48 |
| Colonoscopy | 1.88 | 19.80 | 64.09 | 30.83 |
| Gastroscopy | 3.32 | 24.03 | 59.76 | 29.02 |
| All 15 DM01 tests | 14.20 | 6.42 | 41.54 | 23.14 |
| Community services activity | Medway residents | Kent and Medway ICB |
|---|---|---|
| Care contacts | 43,510 | 254,055 |
| Referrals | 8,580 | 68,085 |
| Patients with a contact | 11,540 | 72,060 |
Community services (residents of Medway), Jun 2026 (provisional). In June 2026 (provisional), 62% of Medway borough residents' community service contacts were with adults aged 65 and over (26,985 of 43,510 contacts). These data reflect local authority resident contacts rather than PCN-specific activity, and contact counts at PCN level were not captured.
Practice variation and patient experience
Practice phone access spans 61.8 pp and good experience varies by 48.6 pp
Overall QOF achievement is 92.5% in England. Overall achievement is 81.2% at The Glebe Family Practice, whereas Pump Lane Surgery achieved 100.0%. In the vaccination and immunisation domain, England achievement is 55.2%. Across captured practices, vaccination and immunisation-domain achievement varies by 84.4 pp: Napier Road Surgery achieved 15.6%, while Pump Lane Surgery achieved 100.0%.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Pump Lane Surgery | 94 | 0.0 | 85.6% | 73.6% | 94.7% |
| Glebe | 96 | 24.2 | 85.8% | 58.9% | 89.9% |
| Napier Road | 98 | 44.0 | 81.3% | 80.7% | 85.2% |
| Woodlands | 124 | 27.1 | 24.0% | 63.9% | 46.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Twelve three-year trends trail England, led by under-80 blood pressure control falling 9.4%
Across 25 compared measures, twelve three-year trends trail England. Under-80 blood pressure control fell 9.4% to 60.1% (England +3.2% to 67.8%), and severe mental illness BMI checks fell 4.4 pp to 78.0% (England +5.1 pp to 82.1%). Dementia register growth was +1.1% (England +6.0%, Medway (LAD) +14.2%), leaving prevalence at 0.5% (145 patients). Conversely, asthma reviews rose 22.3% to 67.8% (England +4.4%), and heart failure functional reviews rose 21.3% to 73.8% (England +8.7%), while learning disability register growth reached +16.2% (England +5.4%, 194 patients).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
BP control, under 80
BMI record (SMI)
Hypertension treated to target
Alcohol record (psychosis)
COPD register
Asthma reviews
Heart failure reviews
COPD reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Medway (LAD) | Asset | PCN | Medway (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 24 (724 beds) | n/a | Schools (catchment) | 72 | n/a |
| Children's centres | 5 | 19 | Places of worship | 37 | 110 |
| Libraries | 2 | 9 | Food banks (VCS) | 1 | 6 |
| Homelessness support (VCS) | n/a | 9 | Day centres (VCS) | 7 | 29 |
| Children and young people (VCS) | 18 | 65 | Carers support groups (VCS) | 2 | 22 |
| Primary schools (LA maintained) | 7 | 17 | Primary academies | 15 | 56 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Under-eighty blood pressure and lipid recall
Across 4,571 hypertension patients (15.0% vs England 15.2%, gap +11 to +77), under-80 BP control fell 6.3 pp to 60.1% (England 67.8%; Woodlands Family Practice 54.4%) and QRISK ≥ 20% lipid therapy is 56.6% (England 63.6%). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
Asthma review and pre-school booster recall
About 560 of 1,752 asthma patients lack a review despite 67.8% coverage (England 65.7%). Age-5 MMR2 (87.5%) and 4-in-1 (86.5%) trail the 95.0% target, with a 6.8 pp MMR dose drop at Woodlands Family Practice. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 3
SMI physical checks and phone access
Across 243 SMI patients (0.8% vs England 1.0%), BMI checks fell 4.4 pp to 78.0% (England 82.1%, +5.1 pp) and BP checks are 78.5% (England 83.4%, -0.3 pp). Phone ease at Woodlands Family Practice is 24.0% (England 56.9%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Severe mental illness health checks (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Under-eighty blood pressure recall (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Childhood booster recall audit (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Targeted breast screening recall (p7) | Breast screening coverage: aged 53 to 70 years old | — | PCN |
| Telephony and triage workflow review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Under-eighty blood pressure and lipid recall (p12) | Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
| Option 2 · Asthma review and pre-school booster recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · MMR dose 1 coverage at age 5 | Core20PLUS5 respiratory | PCN |
| Option 3 · SMI physical checks and phone access (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
